MedInfo World

Empowering patients through shared knowledge and community-driven health insights.

Platform

Drug Information
Health Conditions
Active Ingredients

Support

Help Center
Terms of Use
Privacy Policy
Disclaimer

Company

About Us
Contact

Medical Disclaimer

The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Terms Privacy Disclaimer

Alirocumab – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Home Active IngredientsAlirocumab

Alirocumab

PCSK9 Inhibitor [EPC]

1 Drug4 Variants

Clinical Data

Name

Alirocumab

Raw Name

ALIROCUMAB

Drug Classes

PCSK9 Inhibitor [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Alirocumab.

Mechanism of Action

PCSK9 Inhibitors [MoA]

Chemical Structure

Antibodies, Monoclonal [CS]

Identifiers

RxCUI

1659156, 1659161, 1659165, 1659167, 1659177, 1659179, 1659182, 1659183

UNII

PP0SHH6V16

Drugs with Alirocumab

Medications containing this ingredient

Praluent